Amines Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 49.52%
- Profit Growth 211.45%
- Ebitda 290.54%
- Net Worth 30.54%
- Total Assets 9.77%
About Amines Biotech
Amines Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2003 and has a history of 21 years and six months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ketan Mehta and Himanshu Vyas serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24114GJ2003PTC042681
- Company No.
042681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Amines Biotech Private Limited offer?
Amines Biotech Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Ayurvedic,Herbal Products & Medicine, Ayurvedic Churna and Goli, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Flavours & Aromatics, Beverage Flavors, Food Flavour, Food Additive.
Who are the key members and board of directors at Amines Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Vyas  | Director | 17-Jun-2006 | Current |
| Ketan Mehta | Director | 10-Sep-2015 | Current |
Financial Performance of Amines Biotech.
Amines Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 49.52% increase. The company also saw a substantial improvement in profitability, with a 211.45% increase in profit. The company's net worth Soared by an impressive increase of 30.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amines Biotech?
In 2018, Amines Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amines Biotech?
Unlock and access historical data on people associated with Amines Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amines Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amines Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
